Laurent Moll Sells 42,692 Shares of Arteris (NASDAQ:AIP) Stock

Key Points

• COO Laurent Moll of Arteris sold 42,692 shares at an average price of $8.94, totaling approximately $381,666, which reduced his holdings by 9.66%.
• Arteris stock is currently trading at $8.83, down from a fifty-day moving average of $9.56, and has a market capitalization of $376.60 million.
• Wall Street analysts have a favorable outlook on Arteris, with several rating it as a "buy" and setting an average price target of $15.00.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 42,692 shares of the company's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $8.94, for a total value of $381,666.48. Following the sale, the chief operating officer owned 399,379 shares of the company's stock, valued at approximately $3,570,448.26. This represents a 9.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Arteris Stock Performance

Arteris stock traded down $0.22 during mid-day trading on Wednesday, reaching $8.83. 592,287 shares of the company were exchanged, compared to its average volume of 1,976,387. The business has a fifty day moving average of $9.56 and a 200 day moving average of $8.26. The firm has a market cap of $376.60 million, a P/E ratio of -10.77 and a beta of 1.44. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The company had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.

Hedge Funds Weigh In On Arteris

Institutional investors have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in shares of Arteris in the second quarter worth $32,000. CWM LLC lifted its position in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in Arteris in the first quarter valued at $95,000. Savant Capital LLC acquired a new position in Arteris in the second quarter valued at $97,000. Finally, Kapitalo Investimentos Ltda acquired a new position in Arteris in the second quarter valued at $104,000. Institutional investors and hedge funds own 64.36% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. TD Cowen increased their price objective on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a research report on Saturday. Finally, Rosenblatt Securities reissued a "buy" rating and set a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $15.00.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.